GSK and others can try to bull sheet us with their ideas of how to do the assay. But, at the end of the day, it's the efficacy results that will win the day. Efficacy will determine which assays are more predictive of protection. 11,850 subjects in RSV elderly phase III will do it for NVAX. We don't need to wait for the formal results next Q3. By the end of next Q1, GSK scouts will know how many subjects (placebo & not placebo combined) came down with RSV, and compare to RSV cases in the general populace. Scouts from NVAX, institutions, media and big pharma will all figure it out in Q1 or Q2. I expect the real commotion to start next spring.
They need extra people to speed up the work for RSV elderly phase III, prepare for commercialization that's sure to follow.
Lobster wouldn't know this one. And, if he did, he wouldn't tell. Besides, asking once is one thing, badgering is another. He ain't our mother.
Stan told us in past CC that RSV maternal would take 3 years, give or take. Actually, those who pay attention knew it and talked about it several times since NVAX started working on RSV maternal. If you care about speedy revenue and profits (and lots of it), look at RSV elderly, not maternal.
PATH paid half the external costs of two RSV phase II for non-pregnant women of childbearing age and one phase II for pregnant women. The total was about $8 million.
Little known is the fact that Gates (via PATH) have been supporting RSV maternal phase II for a total of about $8 million, prior to, and on top of this $89 million.
And, no adjuvant at all. One shot, non-adjuvanted, enough to protect tough customers (the elderly). That's quite something.
HAHAHA... Cover before you lose your shorts, fake long. Stan doesn't play games. He executes the business plan with perfection, and that's it. He lets the BOD, with the support of the 72% institutional investors, reward him with well-deserved options. He doesn't need to manipulate public opinion by buying in the open market. He does it by meeting milestones.
You don't need a real doc to answer that question. There are over 100 cold viruses circulating every season. A vaccine would have to be a combo consisting of over 100 vaccines. That would make it very expensive, and would also put a lot of pressure on the immune system, not to mention the side effects.
Sorry, Doc. It's guaranteed 100%. Not 99.99%, not 100.01%, exactly 100%. :)